The Costly burden of drug-resistant TB in the United States

i

The Costly burden of drug-resistant TB in the United States

Public Domain

September 2018
By National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)

File Language:

English

Details

Corporate Authors:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
Description:

Multidrug-resistant (MDR) tuberculosis is a major health threat globally. Nearly half a million MDR TB cases are estimated to occur worldwide annually, including cases that are extensively drug-resistant (XDR).

While MDR and XDR TB are relatively rare in the U.S., their treatment comes at a terrible price – it is very expensive, takes a long time to treat, disrupts lives, and has potentially life-threatening side effects

costly-burden-dr-tb-508.pdf
Subjects:

Cost Of Illness Tuberculosis, Multidrug-Resistant/economics
Document Type:

Poster
Place as Subject:

United States
Pages in Document:

1 poster
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:a68f216f0f0dcef2f1b60bcd41aa50b3438d57042b9a7ff115e74a58e231e1e6
Download URL:

https://stacks.cdc.gov/view/cdc/62365/cdc_62365_DS1.pdf
File Type:

[PDF - 1.31 MB ]

File Language:

English

ON THIS PAGE

Details

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.